Ultragenyx Pharmaceutical Inc - Company Profile
Powered by 
All the sales intelligence you need on Ultragenyx Pharmaceutical Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ultragenyx Pharmaceutical Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ultragenyx Pharmaceutical Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Ultragenyx Pharmaceutical Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Ultragenyx Pharmaceutical Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Daniel G. Welch
Chairman Executive BoardMr. Daniel G. Welch has been the Chairman of the company since 2015. He also serves as the director of Seattle Genetics and Hyperion. Prior to this, he served as the Chairman, Chief Executive Officer, and President of InterMune. Previously, he served as the Chairman and Chief Executive Officer at Triangle Pharmaceuticals Inc.He also served as the President of the Pharmaceutical Division at Elan Corporation, PLC.
Emil D. Kakkis, M.D., Ph.D.
President; Chief Executive Officer; Director Executive BoardDr. Emil D. Kakkis has been the Director, President, and Chief Executive Officer of the company since 2010. He also serves as the President at EveryLife Foundation for Rare Diseases and Director of Odylia Therapeutics. Prior to this, he served as the Chief Medical Officer and Development Consultant at BioMarin Pharmaceutical Inc. Previously, he served as the Board Member at National Organization for Rare Disorders.
Howard Horn
Chief Financial Officer; Executive Vice President - Corporate Strategy Senior ManagementMr. Howard Horn has been the Chief Financial Officer and Executive Vice President of the company since 2023. Prior to this, he served as the Chief Financial Officer of Vir Biotechnology from 2017 to 2023. Previously, he served as the Vice President of Strategic Corporate Finance at Biogen.
Eric Crombez
Chief Medical Officer; Executive Vice President Senior ManagementMr. Eric Crombez has been the Executive Vice President and Chief Medical Officer of the company since 2023. Prior to this, he served as the Chief Medical Officer for Gene Therapy and Inborn Errors of Metabolism of the company. Previously, he served at Shire in its Human Genetics Therapy business unit.
Erik Harris
Executive Vice President; Chief Commercial Officer Senior ManagementMr. Erik Harris has been the Executive Vice President and Chief Commercial Officer of the company since 2019. Prior to this, he served as the Vice President at Crescendo. Previously, he served as the Vice President of Pulmonology Marketing at Intermune, Inc. He also serves as the Director at Rezolute.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer